Clinical Trials Logo
  1. Home
  2. Hemolysis
  3. NCT02976610

Clinical Study of a Novel Hemolysis Point of Care Test at an Emergency Department.

Hemolysis Clinical Trial

Official title:
Open Label, Single Center Clinical Trial of a Novel Hemolysis Point of Care Test at an Emergency Department.

Clinical Trial Summary

This study aims to investigate the outcome of hemolysis frequency when a hemolysis point of care test is introduced in an emergency department.

Clinical Trial Description

In a blood sample process, the preanalytical phase is accountable for a vast majority of laboratory test errors. Among preanalytical errors, hemolysis is the most frequent error of sample rejection. Recollection of blood from the patient causes extra suffering, increased turn-around-time hence delayed treatment, and unnecessary extra costs for the health care system.

Here is a novel method for hemolysis point of care detection (H-POCT) evaluated. The single use test is attached to the blood sample in direct conjunction to the sampling process.

Patients will be selected by consecutive selection at the emergency department if blood tests ordered by the physician meet the inclusion criteria. Patients will be randomized into one of two groups. All health care professionals participating in this study has attended in a standard education program in operating H-POCT.

If Allocated into the control group, n: 750, nurses and enrolled nurses will perform blood sample according to routine.

If allocated into the intervention group, n: 750, nurses and enrolled nurses will perform blood sample according to routine and screen all Lithium Heparin vacuum tubes. (for one or all of the analyzes: Liver status, Electrolytes and Troponin T.)

If the hemolysis point of care test (H-poct) indicate a positive test result the Lithium Heparin vacuum tube and the attached H-poct will be discarded and a new sample will be collected and screened for hemolysis until the user receives a negative sample that is not hemolyzed.

This study takes place in a county hospital with 430 beds and the emergency department treats 59000 patients yearly. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02976610
Study type Interventional
Source Hemcheck Sweden AB
Contact
Status Completed
Phase N/A
Start date December 1, 2016
Completion date May 5, 2017
View Details
See also
  Status Clinical Trial Phase
Completed NCT03439605 - Effect of in Vitro Haemolysis on Serum High Sensitivity Troponin T Measurements From Patients in Accident & Emergency N/A
Completed NCT03434145 - Changes of Ocular Structures After Hemodialysis in Patients With Chronic Kidney Diseases N/A
Completed NCT04084301 - Impact of Cardiopulmonary Bypass Flow on Renal Oxygenation, Blood Flow and Tubular Injury N/A
Not yet recruiting NCT01201174 - Hemolysis in Patients With Hereditary Spherocytosis (HS) N/A
Completed NCT03582592 - Fluid Distribution Timetable on Adherence to Fluid Restriction of Patients With End-Stage Renal Disease on Hemodialysis N/A
Not yet recruiting NCT05754294 - Electric Polarization of Red Blood Cells : A Cohort Study to Assess the Erythrocytes Membrane Integrity Through Charge Conservation, Following Cardiac Surgery.
Completed NCT02996786 - Effects of Danggui Buxue Tang on Blood Biochemical Parameters in Male Recreational Runners N/A
Completed NCT02259478 - Isoagglutinins in the Development of IVIG-associated Hemolysis N/A
Not yet recruiting NCT05647200 - Optimization of Prime Fluid Strategy to Preserve Microcirculatory Perfusion During Cardiac Surgery With Cardiopulmonary Bypass, Part II N/A
Completed NCT05962268 - The Effect Of Vıdeo-Based Fıstula Care Educatıon On Hemodıalysıs N/A
Recruiting NCT06223802 - Biodex Training in Hemodialysis Females With Osteopenia N/A
Active, not recruiting NCT00792779 - Protective Effect of Propofol Against Hemolysis in Patients Submitted to Gastroplasty N/A
Not yet recruiting NCT06096428 - Hemolysis During Pulsed-field and Radiofrequency Ablation
Recruiting NCT03330223 - Effect of Haemodialysis on the Efficacy of Antiplatelet Agents N/A
Completed NCT04203784 - Meropenem and Piperacillin Plasma Concentrations During CRRT
Completed NCT06215339 - Diet Therapy in Hemodialysis Patients N/A
Recruiting NCT05539248 - A Study on the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of CAN106 in Subjects With PNH Phase 1/Phase 2
Recruiting NCT03633435 - Home Hemodialysis Assisted by a Nurse for Arterio-venous Fistula Cannulation N/A
Withdrawn NCT02217683 - Use of Inhaled Nitric Oxide to Prevent Pulmonary Hypertension Associated to Stored Blood Transfusion Phase 2
Completed NCT03199612 - Sildenafil To Prevent Clot Early Phase 1